Kestrel Therapeutics

Allston, United States

Kestrel Therapeutics is a medical research and devenlopment company that offers treatment solutions for RAS cancers.

$40.0M raised

Dec 2021

Series A

Biopharma Biotechnology Health Care Medical

Top Investors

Sante Ventures Pfizer Venture Investments

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Kestrel Therapeutics

How much funding has Kestrel Therapeutics raised?

Kestrel Therapeutics has raised $40.0M in total funding. The most recent round was Series A. The last funding was announced in December 2021.

Who are Kestrel Therapeutics's investors?

Kestrel Therapeutics's investors include Sante Ventures, Pfizer Venture Investments.

Where is Kestrel Therapeutics headquartered?

Kestrel Therapeutics is headquartered in Allston, United States.

What does Kestrel Therapeutics do?

Kestrel Therapeutics is a medical research and devenlopment company that offers treatment solutions for RAS cancers.

What stage is Kestrel Therapeutics at?

Kestrel Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 1, 2021.

MLA

"Kestrel Therapeutics — Funding & Investors." VCBacked, December 1, 2021, https://www.vcbacked.co/company/kestrel-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2021). Kestrel Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/kestrel-therapeutics

Wikipedia (cite web)

{{cite web |title=Kestrel Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/kestrel-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 1, 2021.